王 静,马淑梅

糖尿病肾病（DN）是糖尿病常见且严重的并发症之一，同时也是导致患者终末期肾衰竭的主要致病原因，该患者家庭带来沉重负担。而糖尿病肾病不仅影响肾脏功能，还能显著增加心血管疾病的风险，糖尿病肾病患者心血管疾病（CVD）发病率和死亡率显著高于单纯糖尿病患者，这将严重影响患者的预后和生活质量。随着医学技术的迅速发展，当前争对糖尿病肾病心脏病变的超声检测手段层出不穷，多模态超声技术通过结合多种超声成像方法，能够提供更为全面的心脏结构和功能信息，在糖尿病肾病患者心血管发生事件风险预测中具有显著优势。本文对多模态超声在DN中的研究情况进行如下分析，旨在为临床提供参考。

糖尿病肾病；终末期肾衰竭；心血管疾病；多模态超声

[1] 胡晔,袁明霞.糖尿病肾脏疾病的早期预测指标研究进展[J].中国全科医学,2018,21(3):360-364,369. [2] 钟建林.西药联合中药汤剂治疗糖尿病肾病临床研究[J].中国处方药,2018,16(1):72-73. [3] 陈珍珍,辛光大,李娜,等.血尿酸水平与糖尿病肾病的相关性研究[J].中国实验诊断学,2018,22(2):257-259. [4] 娄群,陈兆杰,姜琦,等.老年糖尿病肾病发病机制､诊断及治疗的研究进展[J].中国老年学杂志,2018,38(1):244-247. [5] 黄俊,李雪梅,杨玉玺,等.糖尿病肾病患者心脏瓣膜钙化危险因素分析[J].四川医学,2017,38(2):162-165. [6] 任晓梅,杨景锋,刘启玲,等.基于基因组学探讨糖尿病肾病的发病原因及其与心血管疾病的关系[J].西安交通大学学报(医学版), 2018,39(2):266-270. [7] Ponikowski P,Voors A A,Anker S D,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur Heart J,2016,37(27):2129-2200. [8] 黄燕萍,奚敏慧,张彬,等.慢性肾脏病患者左心室肥厚的影响因素[J].中国中西医结合肾病杂志,2015,16(11):982-984. [9] 叶霖,吴玉娟,王玉翠.慢性肾功能不全合并左心室肥厚相关因素分析[J].中国预防医学杂志,2019,20(11):1125-1128. [10] Boyer J K,Thanigaraj S,Schechtman K B,et al.Prevalence of ventricular diastolic dysfunction in asymptomatic,normotensive patients with diabetes mellitus[J].Am J Cardiol,2004,93(7):870-875. [11] From A M,Scott C G,Chen H H.The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study[J].J Am Coll Cardiol,2010,55(4):300-305. [12] Poulsen M K,Henriksen J E,Dahl J,et al.Left ventricular diastolic function in type 2 diabetes mellitus:prevalence and association with myocardial and vascular disease[J].Circ Cardiovasc Imaging,2010,3(1):24-31. [13] ČelutkienėJ,Plymen C M,Flachskampf F A,et al.Innovative imaging methods in heart failure:a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology[J].Eur J Heart Fail, 2018,20(12):1615-1633. [14] Cameli M,Mandoli G E,Sciaccaluga C,et al.More than 10 years of speckle tracking echocardiography:Still a novel technique or a definite tool for clinical practice?[J].Echocardiography,2019,36(5):958-970. [15] 杨青梅,张军,苏海砾,刘芳.二维斑点追踪技术对糖尿病患者心脏舒缩功能的研究.临床超声医学杂志.2012,14(3):152-155. [16] Nakai H,Takeuchi M,Nishikage T,et al.Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography:correlation with diabetic duration.Eur J Echocardiogr.2009,10(8):926-32. [17] Mondillo S,Cameli M,Caputo ML,et al.Early detection of left atrial strain abnormalities by speckle-tracking in hypertensive and diabetic patients with normal left atrial size.J Am Soc Echocardiogr.2011,24(8):898-908. [18] Urbano-Moral JA,Patel AR,Maron MS,Arias-Godinez JA,et al.Three-dimensional speckle-tracking echocardiography:methodological aspects and clinical potential.Echocardiography.2012,29(8):997–1010. [19] Muraru D,Niero A,Rodriguez-Zanella H,et al.Three-dimensional speckle-tracking echocardiography:benefits and limitations of integrating myocardial mechanics with three-dimensional imaging[J].Cardiovasc Diagn Ther,2018,8(1):101-117. [20] Perez de Isla L,Balcones DV,Fernandez-Golfin C,et al.Three-dimensional-wall motion tracking:a new and faster tool for myocardial strain assessment:comparison with two-dimensional-wall motion tracking.J Am Soc Echocardiogr.2009,22(4):325–30. [21] Duan F,Xie M,Wang X,et al.Preliminary clinical study of left ventricular myocardial strain in patients with non-ischemic dilated cardiomyopathy by three-dimensional speckle tracking imaging.Cardiovascular Ultrasound.2012,10:8. [22] Ahmad H,Gayat E,Yodwut C,Abduch MC,et al.Evaluation of myocardial deformation in patients with sickle cell disease and preserved ejection fraction using three-dimensional speckle tracking echocardiography.Echocardiography.2012,29(8):962–969. [23] Farhad H,Seidelmann SB,Vigneault D,et al.Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.J Cardiovasc Magn Reson.2017 Dec 28;19(1):107. [24] 张婷婷,周微微,焦晓芳,等.实时三维超声评价肥厚型心肌病患者左心房功能应用价值分析[J].临床军医杂志,2021,49(11):1187-1189. [25] Li Y,Wang Y,Zhai Z,Guo X,Yang Y,Lu X.Real-Time Three-Dimensional Echocardiography to Assess Right Ventricle Function in Patients with Pulmonary Hypertension[J].PLoS One.2015; 10(6):e0129557. [26] Medvedofsky D,Addetia K,Patel AR,et al.Novel Approach to Three-Dimensional Echocardiographic Quantification of Right Ventricular Volumes and Function from Focused Views[J].J Am Soc Echocardiogr.2015;28(10):1222-1231.

点击下载PDF